Advertisement

Acute Myeloid Leukemia

Disease State Hub

Featured

Research Summary
Research Summary
09/20/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers performed a retrospective observational study to determine whether DNA sequencing can detect residual disease in adults with acute myeloid leukemia (AML) in first remission.
09/20/2023
Video
Video
09/13/2023

Alexander Khoruts, MD

Alexander Khoruts, MD
In this video, Alexander Khoruts, MD talks about his team's randomized, double-blind study, which showed that fecal microbiota transplant therapy is safe to use for patients with acute myeloid leukemia...
09/13/2023
Conference Coverage
Conference Coverage
09/06/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether cancer-related cognitive impairment impacts older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy.
09/06/2023
Advertisement

Interactive Features

Pop Quiz
Pop Quiz
08/29/2023
Do you know which genetic mutation is commonly associated with acute myeloid leukemia? Find out in our latest pop quiz!
08/29/2023
Pop Quiz
Pop Quiz
08/10/2023
Do you know the primary purpose of consolidation cytarabine administration in the treatment of adults with acute myeloid leukemia, according to the poster discussion presented at ASCO 2023 titled "Outcomes...
08/10/2023
pop quiz
pop quiz
06/12/2023
Acute myeloid leukemia is one of the most common types of leukemia in adults, but what is the incidence of this type of leukemia among overall cases of cancer? Find out with this pop quiz.
06/12/2023
pop quiz
pop quiz
05/23/2023
Acute myeloid leukemia often causes symptoms rapidly. Are you familiar with common symptoms of acute myeloid leukemia? Take this pop quiz to find out.
05/23/2023

Clinical Insights

Video
Video
09/13/2023

Alexander Khoruts, MD

Alexander Khoruts, MD
In this video, Alexander Khoruts, MD talks about his team's randomized, double-blind study, which showed that fecal microbiota transplant therapy is safe to use for patients with acute myeloid leukemia...
09/13/2023
Expert Q&A
Expert Q&A
08/21/2023

Kendall Diebold, DNP, FNP-C

Kendall Diebold, DNP, FNP-C
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse.1 In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions about her...
08/21/2023
Video
Video
07/25/2023

Ian Bouligny, MD

Ian Bouligny, MD
In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
07/25/2023
Conference Coverage
Conference Coverage
07/17/2023

Kendall Diebold, NP

Kendall Diebold, NP
In this video, Kendall Diebold, DNP, FNP-C, speaks about her team’s research titled “Outcomes of 3- Versus 5-Day Administration Schedule of Consolidation Cytarabine in Adults with Acute Myeloid Leukemia,”...
07/17/2023
Expert Q&A
Expert Q&A
08/21/2015

Ian Bouligny, MD

Ian Bouligny, MD
In this Q&A, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
08/21/2015